Crown – Buy

The current weakness in the Crown share price could be a buying opportunity. It’s unlikely that the current COVID-related operational impacts are going to deter the interested parties who have put forward takeover offers.

Continue to track the CWN share price and wait for a cross above the 10-day average.

12/8 update: CWN is now trading above the 10 day average.

18/10 update: Crown recovery continues, buy with a stop loss below $8.75

Appen – Earnings Review

Machine learning and AI specialist Appen (APX) has downgraded its earnings guidance due to the COVID-19 pandemic downturn.

The company’s guidance is for EBITDA in the range of $100 million to $110 and the company anticipates a return to strong growth in FY22.